Antimicrobial drugs are widely used around the world to treat infections. However, the overuse of antimicrobials has resulted ...

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be ...

The trial compares Eli Lilly’s lutetium zadavotide guraxetan with Astellas’s Xtandi or Janssen’s Zytiga for mPRPC.

Oncternal is halting the development of two cancer candidates, ONCT-534 and ONCT-808, after disappointing trial results.

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

Pfizer’s cancer cachexia candidate has provided patients with clinically meaningful weight gain in a Phase II trial, with the ...

Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who ...

Moderna's mRNA-4359 has shown early signs of efficacy, activating key proteins to trigger an immune response for cancer ...

As Ipsen pivots away from Cabometyx in mCRPC, US rights holder Exelixis will press ahead with a submission to the FDA.

No drug specifically targets the underlying pathophysiological processes that cause sepsis and only symptomatic treatments ...

Alio’s SmartPatch was cleared by the US FDA to measure multiple health metrics, including clinical markers, blood pressure ...

In the last couple of days at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting 2024, the ...